Naturally Occurring Mutations within 39 Amino Acids in the Envelope Glycoprotein of Maedi-Visna Virus Alter the Neutralization Phenotype
暂无分享,去创建一个
Robert Skraban | V. Andrésdóttir | G. Georgsson | R. Meloen | Ó. Andrésson | H. Thormar | K. Staskus | S. Torsteinsdottir | S. Matthíasdóttir | G. Agnarsdóttir | B. Gudmundsson
[1] B. Meyer,et al. The V3-directed immune response in natural human immunodeficiency virus type 1 infection is predominantly directed against a variable, discontinuous epitope presented by the gp120 V3 domain , 1997, Journal of virology.
[2] V. Andrésdóttir,et al. In vivo and in vitro infection with two different molecular clones of visna virus. , 1997, Virology.
[3] O. Narayan,et al. Plasmas from lymphocyte- and macrophage-tropic SIVmac-infected macaques have antibodies with a broader spectrum of virus neutralization activity in macrophage versus lymphocyte cultures. , 1997, Virology.
[4] J. Clements,et al. Antigenic variation of SIV: mutations in V4 alter the neutralization profile. , 1996, Virology.
[5] Stephen C. Peiper,et al. Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.
[6] Paul E. Kennedy,et al. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.
[7] A. Trkola,et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 , 1996, Journal of virology.
[8] F. Guiguen,et al. Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses , 1996, Journal of virology.
[9] A. Osterhaus,et al. Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein , 1995, Journal of virology.
[10] Marian C. Horzinek,et al. A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells , 1995, Journal of virology.
[11] R. Weiss,et al. Change in tropism upon immune escape by human immunodeficiency virus , 1995, Journal of virology.
[12] R. F. Cook,et al. Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein , 1995, Journal of virology.
[13] R. Desrosiers,et al. Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity , 1994, Journal of virology.
[14] M. Bendinelli,et al. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system , 1994, Journal of virology.
[15] L. Sawyer,et al. Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated , 1994, Journal of virology.
[16] J. Sodroski,et al. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding , 1993, Journal of virology.
[17] M. Reitz,et al. Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. , 1993, The Journal of biological chemistry.
[18] A. Osterhaus,et al. A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization , 1993, Journal of virology.
[19] J. D. Greenwood,et al. Nucleotide sequence and biological properties of a pathogenic proviral molecular clone of neurovirulent visna virus. , 1993, Virology.
[20] J. Moore,et al. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans , 1993, Journal of virology.
[21] R. Desrosiers,et al. The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. Kuiken,et al. Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. , 1991, Virology.
[23] R. Dalziel,et al. Nucleotide sequence of EV1, a British isolate of maedi-visna virus. , 1991, The Journal of general virology.
[24] A. Haase,et al. Isolation of replication-competent molecular clones of visna virus. , 1991, Virology.
[25] J. Clements,et al. Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. , 1990, Virology.
[26] R. Gallo,et al. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees , 1990, Journal of virology.
[27] G. Quérat,et al. Nucleotide sequence analysis of SA-OMVV, a visna-related ovine lentivirus: phylogenetic history of lentiviruses. , 1990, Virology.
[28] J. Albert,et al. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. , 1990, AIDS.
[29] L. Pearl,et al. Characterization of HIV‐1 neutralization escape mutants , 1989, AIDS.
[30] L. Arthur,et al. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[31] A J Langlois,et al. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Braun,et al. The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins , 1987, Journal of virology.
[33] G. Nakamura,et al. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor , 1987, Cell.
[34] H. Gendelman,et al. Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages , 1986, Journal of virology.
[35] A. Haase,et al. Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus , 1985, Cell.
[36] H. M. Geysen,et al. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[37] H. Thormar,et al. The emergence of antigenic variants is a rare event in long-term visna virus infection in vivo. , 1983, The Journal of general virology.
[38] G. Georgsson,et al. Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep. , 1983, The Journal of general virology.
[39] J. Clements,et al. Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. , 1982, The Journal of general virology.
[40] D. Griffin,et al. Antigenic shift of visna virus in persistently infected sheep. , 1977, Science.
[41] H. Panitch,et al. Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies. , 1976, Laboratory investigation; a journal of technical methods and pathology.
[42] B. Sigurdsson,et al. Visna of sheep; a slow, demyelinating infection. , 1958, British journal of experimental pathology.
[43] B SIGURDSSON,et al. Maedi, a chronic, progressive infection of sheep's lungs. , 1952, The Journal of infectious diseases.
[44] M. Sitbon,et al. Conserved framework of envelope glycoproteins among lentiviruses. , 1994, Current topics in microbiology and immunology.
[45] G. Georgsson. Maedi - Visna. Pathology and Pathogenesis , 1990 .
[46] G. Pétursson,et al. Maedi-Visna and Related Diseases , 1990, Developments in Veterinary Virology.
[47] C. Boucher,et al. Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition. , 1988, AIDS.
[48] G. Georgsson,et al. Pathogenesis of Visna , 1987 .
[49] M. Gudnadóttir. Visna-maedi in sheep. , 1974, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.